×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NASDAQ:SILK

Silk Road Medical Stock Forecast, Price & News

$39.63
+0.46 (+1.17%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$38.41
$39.88
50-Day Range
$28.03
$45.80
52-Week Range
$27.21
$67.49
Volume
441,180 shs
Average Volume
318,103 shs
Market Capitalization
$1.39 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
30 days | 90 days | 365 days | Advanced Chart

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock Forecast (MarketRank)

Overall MarketRank

1.72 out of 5 stars

Medical Sector

877th out of 1,417 stocks

Surgical & Medical Instruments Industry

94th out of 138 stocks

Analyst Opinion: 3.3Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
Silk Road Medical logo

About Silk Road Medical (NASDAQ:SILK)

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Company Calendar

Last Earnings
5/04/2022
Today
6/25/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$66.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+26.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.6
Research Coverage
5 Analysts

Profitability

Net Income
$-49.81 million
Pretax Margin
-51.93%

Debt

Sales & Book Value

Annual Sales
$101.47 million
Book Value
$2.27 per share

Miscellaneous

Free Float
32,412,000
Market Cap
$1.39 billion
Optionable
Not Optionable
Beta
1.59














Silk Road Medical Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2022?

5 equities research analysts have issued 1-year price targets for Silk Road Medical's stock. Their SILK stock forecasts range from $33.00 to $66.00. On average, they expect Silk Road Medical's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 26.2% from the stock's current price.
View analysts' price targets for Silk Road Medical
or view top-rated stocks among Wall Street analysts.

How has Silk Road Medical's stock price performed in 2022?

Silk Road Medical's stock was trading at $42.61 at the beginning of 2022. Since then, SILK shares have decreased by 7.0% and is now trading at $39.63.
View the best growth stocks for 2022 here
.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.07. The company earned $28 million during the quarter, compared to analyst estimates of $27.10 million. Silk Road Medical had a negative net margin of 51.93% and a negative trailing twelve-month return on equity of 67.38%. Silk Road Medical's revenue for the quarter was up 39.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.31) EPS.
View Silk Road Medical's earnings history
.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $127.00 million-$132.00 million, compared to the consensus revenue estimate of $129.54 million.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wasatch Advisors Inc. (11.71%), Vanguard Group Inc. (8.67%), Capital World Investors (7.95%), BlackRock Inc. (7.32%), Deerfield Management Company L.P. Series C (6.17%) and Clearbridge Investments LLC (3.91%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Andrew S Davis, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends for Silk Road Medical
.

Which major investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Granahan Investment Management LLC, Northern Trust Corp, TimesSquare Capital Management LLC, Rhenman & Partners Asset Management AB, Bank Julius Baer & Co. Ltd Zurich, Goldman Sachs Group Inc., and First Trust Advisors LP. Company insiders that have sold Silk Road Medical company stock in the last two years include Andrew S Davis, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, and Richard Ruedy.
View insider buying and selling activity for Silk Road Medical
or view top insider-selling stocks.

Which major investors are buying Silk Road Medical stock?

SILK stock was acquired by a variety of institutional investors in the last quarter, including Deerfield Management Company L.P. Series C, Wasatch Advisors Inc., American Century Companies Inc., Novo Holdings A S, Massachusetts Financial Services Co. MA, Next Century Growth Investors LLC, Bellevue Group AG, and Landscape Capital Management L.L.C..
View insider buying and selling activity for Silk Road Medical
or or view top insider-buying stocks.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $39.63.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.39 billion and generates $101.47 million in revenue each year. The company earns $-49.81 million in net income (profit) each year or ($1.61) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for Silk Road Medical is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at [email protected], or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.